Patrick Walsh
Pediatrics · Anaheim, CANPI 1588608285
Payments from drug & device makers
What this record shows
That places this record below the midpoint for pediatrics clinicians in CA, where the typical reported total is $170.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$2,997,597in research payments, 2019–2025
Across 142 payments — averaging $21,110 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$2.6M
- Eli Lilly$172K
- AbbVie$71K
- Neurocrine Biosciences, Inc.$55K
- Shire North American Group Inc$40K
- Takeda Pharmaceuticals U.S.A., Inc.$14K
- plus $18K from 4 others
How this compares
$0 in reported general payments places this provider in the 0th percentile of 5,539 pediatrics providers in California.
Other pediatrics in Anaheim
- Jonathan LinAnaheim$80K
- Laurene MascolaLos Angeles$451K
- Tonya ChaffeeSan Francisco$359K
- Anthony PortaleSan Francisco$354K
- David KesslerSan Francisco$335K
- Lawrence SherRolling Hills Estates$297K
- Steven BlackOakland$228K
- Jonathan StroberSan Francisco$164K
- Hasmukh AminBakersfield$140K
- Colleen KraftNewport Beach$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.